BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/09/2005

FDA Withdraws Penthrane Inhalation Liquid Due to Safety Concerns

The Food and Drug Administration has withdrawn Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent, from sale due to concerns over its safety and effectiveness, and will no longer accept new drug applications for this product.

Source: Federal Register — Food and Drug AdministrationOpen original release →